Zain Guduru - Projects & Grants - University of Kentucky

h-index

Research activity per year

1 Active
9 Finished

10 results

Active

JZP385-202: A 17-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Flexible-dosing, Parallel-group, Multicenter Study of the Efficacy and Safety of Suvecaltamide in the Treatment of Moderate to Severe Residual Tremor in Participants with Parkin
Guduru, Z. (PI)
Cavion Incorporated
8/17/23 → 8/17/25
Project: Research project
Finished

IRL790C005: A Randomized, Double-Blind, Placebo-Controlled, Phase IIb Study Evaluating the Efficacy of Mesdopetam on Daily ON-Time Without Troublesome Dyskinesia in Patients with Parkinson#s Disease
Guduru, Z. (PI)
Integrative Research Laboratories Sweden AB
5/27/21 → 2/28/23
Project: Research project
CVL-751-PD-004: 58-Week Open-label Trial of Tavapadon in Parkinson's Disease (TEMPO-4 Trial)
Guduru, Z. (PI)
Syneos Health LLC
12/10/20 → 5/2/23
Project: Research project
RAD-PD: Registry for the Advancement of DBS in Parkinson's Disease
Guduru, Z. (PI)
Neuropoint Alliance Incorporated
10/9/20 → 5/2/22
Project: Research project
CVL-751-PD-003: A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Flexible-Dose, 27-Week Trial to Evaluate the Efficacy, Safety, and Tolerability of Tavapadon as Adjunctive Therapy for Parkinson's Disease in Levodopa-Treated Adults
Guduru, Z. (PI)
Syneos Health LLC
8/3/20 → 10/12/23
Project: Research project
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, 27-Week Trial of the Efficacy, Safety, and Tolerability of Two Fixed Doses of Tavapadon in Early Parkinson's Disease
Guduru, Z. (PI)
Syneos Health LLC
5/20/20 → 4/3/23
Project: Research project
Trial Of Parkinson's And Zoledronic Acid (TOPAZ)
Slevin, J. (PI), Guduru, Z. (CoI) & Yamasaki, T. (CoI)
Parkinsons Foundation
4/29/20 → 6/1/24
Project: Research project
Molecular and Functional Biomarkers of Parkinson's Disease
Guduru, Z. (PI)
Quadrant Biosciences Incorporated
4/1/20 → 4/8/21
Project: Research project
P2B001: A Phase 3, Twelve-week, Multi-Center, Multinational, Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Determine the Efficacy, Safety and Tolerability of P2B001 Once Daily Compared to its Individual Components in Subjects With Early
Guduru, Z. (PI)
Pharmaceutical Research Associates
3/12/18 → 1/18/22
Project: Research project
M15-739: An Open-Label Study in Subjects with Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 for up to 4 Weeks in an Outpatient Environment
Slevin, J. (PI) & Guduru, Z. (CoI)
AbbVie Incorporated
2/28/18 → 1/6/20
Project: Research project

Your message has successfully been sent.

Your message was not sent due to an error.